252 related articles for article (PubMed ID: 26043812)
1. Evaluation of store lesion in platelet obtained by apheresis compared to platelet derived from whole blood and its impact on the in vitro functionality.
Quintero M; Núñez M; Mellado S; Maldonado M; Wehinger S
Transfus Apher Sci; 2015 Dec; 53(3):293-9. PubMed ID: 26043812
[TBL] [Abstract][Full Text] [Related]
2. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
[TBL] [Abstract][Full Text] [Related]
4. Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days.
Hussein E
Transfus Med; 2015 Feb; 25(1):20-6. PubMed ID: 25808050
[TBL] [Abstract][Full Text] [Related]
5. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.
Stohlawetz P; Horvath M; Pernerstorfer T; Nguyen H; Vondrovec B; Robisch A; Eichler HG; Spitzauer S; Jilma B
Transfusion; 1999 May; 39(5):506-14. PubMed ID: 10336001
[TBL] [Abstract][Full Text] [Related]
6. Assessment of soluble platelet CD40L and CD62P during the preparation process and the storage of apheresis platelet concentrates: Absence of factors related to donors and donations.
Sut C; Aloui C; Tariket S; Arthaud CA; Eyraud MA; Fagan J; Chavarin P; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
Transfus Clin Biol; 2018 Sep; 25(3):192-196. PubMed ID: 30033079
[TBL] [Abstract][Full Text] [Related]
7. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
Glas M; Bauer JV; Eichler H; Volk T
Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
[TBL] [Abstract][Full Text] [Related]
8. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
Charania R; Smith J; Vesely SK; Dale GL; Holter J
Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
[TBL] [Abstract][Full Text] [Related]
10. Increasing susceptibility of nitric oxide-mediated inhibitory platelet signaling during storage of apheresis-derived platelet concentrates.
Kobsar A; Klinker E; Kuhn S; Koessler A; Yilmaz P; Boeck M; Koessler J
Transfusion; 2014 Jul; 54(7):1782-9. PubMed ID: 24576258
[TBL] [Abstract][Full Text] [Related]
11. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
12. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
Sloand EM; Yu M; Klein HG
Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
[TBL] [Abstract][Full Text] [Related]
13. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
14. Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ₃ and focal adhesion signaling pathways.
Thiele T; Iuga C; Janetzky S; Schwertz H; Gesell Salazar M; Fürll B; Völker U; Greinacher A; Steil L
J Proteomics; 2012 Dec; 76 Spec No.():297-315. PubMed ID: 22634086
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.
Dzieciatkowska M; D'Alessandro A; Burke TA; Kelher MR; Moore EE; Banerjee A; Silliman CC; West BF; Hansen KC
J Proteomics; 2015 Jan; 112():190-209. PubMed ID: 25201077
[TBL] [Abstract][Full Text] [Related]
17. Platelet concentrates, from whole blood or collected by apheresis?
van der Meer PF
Transfus Apher Sci; 2013 Apr; 48(2):129-31. PubMed ID: 23535511
[TBL] [Abstract][Full Text] [Related]
18. Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates.
Marini I; Aurich K; Jouni R; Nowak-Harnau S; Hartwich O; Greinacher A; Thiele T; Bakchoul T
Haematologica; 2019 Jan; 104(1):207-214. PubMed ID: 30115655
[TBL] [Abstract][Full Text] [Related]
19. Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5.
Morrison A; McMillan L; Radwanski K; Blatchford O; Min K; Petrik J
Vox Sang; 2014 Oct; 107(3):247-53. PubMed ID: 24801569
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
